Bose is exiting the hearing aid market, according to an article in Tuesday’s “Boston Globe.” The Bose SoundControl hearing aid was the first FDA-cleared self-fitting hearing aid for mild-to-moderate hearing losses, and helped define this distinct class of devices. It’s possible the technology will be licensed or sold to another company.
Read More
As insurance coverage for hearing care services continues to grow and assume greater importance, so do the the myriad Current Procedural Terminology (CPT) codes that practices must use for reimbursement. But who actually creates these codes, and how are they established? Robert Fifer, PhD, an audiologist in the Department of Pediatrics at the University of Miami Miller School of Medicine, is one of the leading experts in CPT codes in hearing care and has been working with professional organizations in this area for nearly 30 years.
Read More
This is Part 2 of a two-part series looking at why audiologists should consider transitioning to a person-centered approach —especially in light of developments around over-the-counter devices — and how they can make the mindset, practice, and business changes required.
Read More
MarkeTrak 2022 updates and extends the findings of MT10 (2019) generated by this series of consumer surveys—the most comprehensive and oldest of its kind, dating back to 1989—of hearing aid users and non-users in the United States. In particular, MT2022 includes new information about hearing aid use by gender and race, and also includes data on cochlear implant use and personal sound amplification products (PSAPs), as well as the emerging class of what may soon become over-the-counter (OTC) hearing aids.
Read More
Nuheara has announced a worldwide Trademark License Agreement to develop, manufacture and market its hearing aid products under the leading HP brand trademarks through the end of 2027.
Read More
The IHS Board of Governors have named Alissa Parady as executive director of IHS. Formerly the IHS Director of Government and Chapter Affairs, Parady will work closely with the IHS Board to execute their strategic initiatives to the benefit of the hearing healthcare professionals who comprise IHS membership.
Read More
What do the recent mergers and acquisitions (M&As) of hearing care dispensing networks mean for private practice audiologists and hearing aid specialists?
Read More
The HLAA has been busy working with the FDA, FTC, FCC, HHS, NIDCD, CTA, and the various professional and industry groups in hearing healthcare on virtually everything related to hearing and access issues.
Read More
The American Academy of Audiology (AAA) 2022 Convention in St Louis attracted about 2,200 people for four days of excellent learning opportunies, networking, and fun. Academy leaders are urging members to become more involved in this era of rapid change.
Read More
Nuheara Limited (ASX:NUH) (Company or Nuheara) announced that it has taken the final step in its plans to secure US Food and Drug Administration (FDA) clearance for its self-fitting hearing aid by providing its 510(k) submission to the FDA.
Read More
Why person-centered care is the answer to OTC hearing aids…and much more.
Read More
Specific Signia hearing aids that will be spotlighted at the show include the Signia Insio Charge&Go AX, the “world’s first custom hearing aid with contactless charging and streaming to iOS and Android,” and Signia Pure Charge&Go T AX, the company’s “smallest receiver-in-canal hearing aid to date” that comes standard with telecoil.
Read More
WS Audiology, the parent company of Signia and Widex, has postponed its plans to submit its subsidiary, Hear.com, for an IPO “due to current challenging equity market conditions.”
Read More
Mergers and acquisitions came back strong in 2021 after the pandemic, and M&As have started strong in 2022.
Read More
Under the terms of the agreement, Altaris will acquire all outstanding shares of Intricon for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million. The purchase price represents a meaningful premium of approximately 39% to Intricon’s closing stock price on February 25, 2022.
Read More